Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).

@article{Ruwald2014MortalityRI,
  title={Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).},
  author={Anne-Christine Ruwald and Claudio D. Schuger and Arthur J. Moss and Valentina Kutyifa and Brian Olshansky and Henry Greenberg and David S. Cannom and N. A. Mark Estes and Martin H Ruwald and David T. Huang and Helmut U Klein and Scott McNitt and Christopher A. Beck and Robert H. Goldstein and Mary W. Brown and Josef Kautzner and Morio Shoda and David J. Wilber and Wojciech Zareba and James P Daubert},
  journal={Circulation. Arrhythmia and electrophysiology},
  year={2014},
  volume={7 5},
  pages={785-92}
}
BACKGROUND The benefit of novel implantable cardioverter defibrillator (ICD) programming in reducing inappropriate ICD therapy and mortality was demonstrated in Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT). However, the cause of mortality reduction remains incompletely evaluated. We aimed to identify factors associated with mortality, with focus on ICD therapy and programming in the MADIT-RIT population. METHODS AND RESULTS In MADIT-RIT, 1500… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS